Peter Thiel, the co-founder of PayPal and a Facebook investor, is also interested in biotech, especially in companies that can methodically put their ideas into practice, writes Antonio Regalado at MIT's Technology Review. Too often, Thiel says, companies wind up spending a lot of money trying to come up with drugs that may not even work.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.

Bill Gates tells the Telegraph that bioterrorism is a serious risk.

The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.

CBS News reports that the White House Science Fair is to continue under President Donald Trump.